ATE183643T1 - Rektale zusammensetzungen enthaltend odansetron als freie base - Google Patents

Rektale zusammensetzungen enthaltend odansetron als freie base

Info

Publication number
ATE183643T1
ATE183643T1 AT94918355T AT94918355T ATE183643T1 AT E183643 T1 ATE183643 T1 AT E183643T1 AT 94918355 T AT94918355 T AT 94918355T AT 94918355 T AT94918355 T AT 94918355T AT E183643 T1 ATE183643 T1 AT E183643T1
Authority
AT
Austria
Prior art keywords
odansetron
free base
compositions containing
rectal compositions
rectal
Prior art date
Application number
AT94918355T
Other languages
English (en)
Inventor
Isabelle Thielemans
Isabelle Richard
Original Assignee
Glaxo Wellcome Lab Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Wellcome Lab Sa filed Critical Glaxo Wellcome Lab Sa
Application granted granted Critical
Publication of ATE183643T1 publication Critical patent/ATE183643T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT94918355T 1993-05-25 1994-05-24 Rektale zusammensetzungen enthaltend odansetron als freie base ATE183643T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939310756A GB9310756D0 (en) 1993-05-25 1993-05-25 Compositions

Publications (1)

Publication Number Publication Date
ATE183643T1 true ATE183643T1 (de) 1999-09-15

Family

ID=10736089

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94918355T ATE183643T1 (de) 1993-05-25 1994-05-24 Rektale zusammensetzungen enthaltend odansetron als freie base

Country Status (38)

Country Link
US (1) US5741806A (de)
EP (1) EP0700290B1 (de)
JP (1) JP2965703B2 (de)
KR (1) KR100297212B1 (de)
CN (1) CN1106194C (de)
AP (1) AP544A (de)
AT (1) ATE183643T1 (de)
AU (1) AU680918B2 (de)
BE (1) BE1007158A3 (de)
BR (1) BR1100046A (de)
CA (1) CA2162919C (de)
CO (1) CO4230094A1 (de)
CY (1) CY2411B1 (de)
CZ (1) CZ291041B6 (de)
DE (1) DE69420266T2 (de)
DK (1) DK0700290T3 (de)
EC (1) ECSP941088A (de)
ES (1) ES2136198T3 (de)
FR (1) FR2705569B1 (de)
GB (2) GB9310756D0 (de)
GR (1) GR3031669T3 (de)
HR (2) HRP940315B1 (de)
HU (1) HU227121B1 (de)
IE (1) IE80632B1 (de)
IL (1) IL109749A (de)
IS (1) IS1868B (de)
IT (1) IT1272990B (de)
MY (1) MY111445A (de)
NO (1) NO306448B1 (de)
NZ (1) NZ267415A (de)
PE (1) PE13395A1 (de)
PL (1) PL175578B1 (de)
RU (1) RU2132684C1 (de)
SA (1) SA94150003B1 (de)
SG (1) SG48119A1 (de)
SI (1) SI0700290T1 (de)
WO (1) WO1994027599A1 (de)
ZA (1) ZA943593B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20060067986A (ko) * 1998-06-15 2006-06-20 세프라코 아이엔시. 무호흡증, 대식증, 다른 질환을 치료하기 위한 광학적으로순수한 (+)-노르씨사프라이드의 용도
EP1464333A3 (de) * 1998-06-15 2004-12-15 Sepracor Inc. Verwendung von optisch reines (-) Norcisapride in der Behandlung von Apnea, Bulimia und andere Krankheiten
EP1468685A3 (de) * 1998-06-15 2004-12-15 Sepracor Inc. Verwendung von optisch reines (+)-Norcisapride für die Behandlung von Apnea, Bulimia und andere Krankheiten
TR200003707T2 (tr) * 1998-06-15 2001-06-21 Sepracor Inc. Apne , bulimi ve başka bozuklukların tedavi edilmesi için optik açıdan saf (-) norsisapridin kullanımı
US6362202B1 (en) 1999-03-02 2002-03-26 Sepracor Inc. Methods and compositions using (−) norcisapride in combination with proton pump inhibitors or H2 receptor antagonists
US6353005B1 (en) 1999-03-02 2002-03-05 Sepracor, Inc. Method and compositions using (+) norcisapride in combination with proton pump inhibitors or H2 receptor antagonist
JP5048201B2 (ja) * 2000-08-04 2012-10-17 ディーエムアイ バイオサイエンシズ インコーポレイテッド ジケトピペラジン類の使用方法とジケトピペラジン類を含む組成物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4695578A (en) * 1984-01-25 1987-09-22 Glaxo Group Limited 1,2,3,9-tetrahydro-3-imidazol-1-ylmethyl-4H-carbazol-4-ones, composition containing them, and method of using them to treat neuronal 5HT function disturbances
PH22672A (en) * 1984-01-25 1988-11-14 Glaxo Group Ltd Imidazolylmethyltetrahydrocarbazolone derivatives, composition and method of use thereof
GB8516083D0 (en) * 1985-06-25 1985-07-31 Glaxo Group Ltd Heterocyclic compounds
GB8627909D0 (en) * 1986-11-21 1986-12-31 Glaxo Group Ltd Medicaments
GB8816187D0 (en) * 1988-07-07 1988-08-10 Glaxo Group Ltd Medicaments
GB8914804D0 (en) * 1989-06-28 1989-08-16 Glaxo Group Ltd Process
US5166145A (en) * 1990-09-10 1992-11-24 Alza Corporation Antiemetic therapy

Also Published As

Publication number Publication date
EP0700290A1 (de) 1996-03-13
CN1106194C (zh) 2003-04-23
GR3031669T3 (en) 2000-02-29
IE940420A1 (en) 1994-11-30
CN1124454A (zh) 1996-06-12
NO306448B1 (no) 1999-11-08
GB9310756D0 (en) 1993-07-14
FR2705569A1 (fr) 1994-12-02
DK0700290T3 (da) 2000-03-13
IL109749A0 (en) 1994-08-26
ES2136198T3 (es) 1999-11-16
GB9409835D0 (en) 1994-07-06
IE80632B1 (en) 1998-10-21
HRP940315B1 (en) 2000-12-31
KR100297212B1 (ko) 2001-10-24
HUT74867A (en) 1997-02-28
IT1272990B (it) 1997-07-01
MY111445A (en) 2000-05-31
WO1994027599A1 (en) 1994-12-08
CA2162919A1 (en) 1994-12-08
CO4230094A1 (es) 1995-10-19
AP9400643A0 (en) 1994-07-31
DE69420266T2 (de) 1999-12-09
BE1007158A3 (fr) 1995-04-11
IL109749A (en) 1999-03-12
JPH08510457A (ja) 1996-11-05
CZ308595A3 (en) 1996-06-12
ITRM940322A1 (it) 1995-11-24
FR2705569B1 (fr) 1995-11-10
ITRM940322A0 (it) 1994-05-24
HU227121B1 (en) 2010-07-28
RU2132684C1 (ru) 1999-07-10
HRP940315A2 (en) 1996-08-31
IS4168A (is) 1994-11-26
CY2411B1 (en) 2004-11-12
AU680918B2 (en) 1997-08-14
SG48119A1 (en) 1998-04-17
IS1868B (is) 2003-05-02
CA2162919C (en) 1999-07-20
SA94150003B1 (ar) 2005-04-11
GB2279008A (en) 1994-12-21
JP2965703B2 (ja) 1999-10-18
SI0700290T1 (en) 1999-12-31
HRP970315A2 (en) 1999-04-30
US5741806A (en) 1998-04-21
BR1100046A (pt) 1999-11-23
ZA943593B (en) 1995-02-13
PL311721A1 (en) 1996-03-04
NO954783L (no) 1995-11-24
AP544A (en) 1996-10-11
NZ267415A (en) 1997-10-24
PE13395A1 (es) 1995-05-25
DE69420266D1 (de) 1999-09-30
NO954783D0 (no) 1995-11-24
PL175578B1 (pl) 1999-01-29
ECSP941088A (es) 1994-11-16
AU6970994A (en) 1994-12-20
EP0700290B1 (de) 1999-08-25
HU9503375D0 (en) 1996-01-29
GB2279008B (en) 1997-06-18
CZ291041B6 (cs) 2002-12-11

Similar Documents

Publication Publication Date Title
DE69433204D1 (de) Markierung als bezugspunkt
DE69423670D1 (de) Siloxy-aluminoxan-Zusammensetzungen
FI955420A7 (fi) BMP-10 koostumukset
FI954727L (fi) Uusia virusvastaisia yhdisteitä
FI961720L (fi) Uusi koostumus
DE69414492D1 (de) Schmelzverarbeitbare Mischung
FI954016A7 (fi) Uudet yhdisteet
DE69309769D1 (de) Positivarbeitende Resistzusammensetzung
BR9406627A (pt) Composições antiparasiticas
DE69315641D1 (de) Base extrahierbare Petroleumskennzeichen
DE69408161D1 (de) Reinigungsmittelzusammensetzungen
DE69310162D1 (de) Pegelumsetzungsschaltung
DE69420266D1 (de) Rektale zusammensetzungen enthaltend odansetron als freie base
FI944846A0 (fi) Johtava lakkaformulaatti
ITMI920466A1 (it) Composizioni polimeriche a base di copoliammidi
ITMI930785A0 (it) Interruttore scatolato sezionabile
DE69412822D1 (de) Waschmittelzusammensetzungen
BR9005251A (pt) Composicao detergente a base de agua
DE69405735D1 (de) Waschmittelzusammensetzungen
FI954017A7 (fi) Uudet yhdisteet
DE69305613D1 (de) Härtbare Zusammensetzungen
IT1176067B (it) Composizioni deodorate a base di composti organotiofosforati
ITBO920022A1 (it) Composizione verniciante a base acquosa
FI941309L (fi) Substituoituja pyridopyrmidiinejä korkean verenpaineen vastaisina aineina
DK102693D0 (da) Novel compounds

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification